- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2017
- Public Summary Document (PSD) November 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2017 PBAC Meeting - Word
Lenalidomide – November 2017
Lenalidomide: Capsule 5 mg, Capsule 10 mg, Capsule 15 mg, Capsule 25 mg; Revlimid®
Last updated
2 March 2018